Teva Pharmaceutical Industries Limited (VIE:TEVA)

VIE:TEVA Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 3, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	27,950	24,154	10,588	9,478	7,769	8,646
Market Cap Growth	58.11%	128.13%	11.71%	22.00%	-10.15%	-9.34%
Enterprise Value	40,719	39,874	27,443	28,328	28,089	29,300
Last Close Price	24.20	21.90	9.36	8.66	7.48	7.78
PE Ratio	45.99	-	-	-	21.19	-
PS Ratio	1.95	1.51	0.74	0.68	0.56	0.64
PB Ratio	4.52	4.37	1.44	1.18	0.79	0.96
P/FCF Ratio	56.74	33.39	13.90	9.72	37.44	16.58
P/OCF Ratio	30.76	20.05	8.56	6.37	11.07	8.70
EV/Sales Ratio	2.83	2.50	1.91	2.03	2.01	2.15
EV/EBITDA Ratio	10.06	9.32	7.00	7.63	7.25	7.77
EV/EBIT Ratio	13.32	12.24	9.54	11.37	10.38	11.73
EV/FCF Ratio	82.66	55.12	36.03	29.06	135.36	56.18
Debt / Equity Ratio	2.36	3.18	2.50	2.52	2.10	2.40
Debt / EBITDA Ratio	3.62	3.98	4.53	5.26	5.19	5.57
Debt / FCF Ratio	29.57	24.28	24.08	20.80	99.97	41.59
Asset Turnover	0.41	0.40	0.36	0.33	0.32	0.31
Inventory Turnover	2.30	2.41	2.09	2.08	2.02	2.02
Quick Ratio	0.52	0.50	0.54	0.57	0.61	0.51
Current Ratio	1.11	0.98	1.02	1.05	1.14	0.99
Return on Equity (ROE)	9.71%	-28.30%	-7.36%	-25.19%	4.09%	-31.38%
Return on Assets (ROA)	5.45%	5.09%	4.54%	3.63%	3.91%	3.53%
Return on Capital (ROIC)	8.90%	8.06%	6.78%	5.11%	5.31%	4.77%
Return on Capital Employed (ROCE)	12.60%	12.70%	10.20%	8.20%	8.40%	8.20%
Earnings Yield	2.17%	-6.55%	-4.78%	-24.15%	4.72%	-37.73%
FCF Yield	1.76%	3.00%	7.20%	10.29%	2.67%	6.03%
Buyback Yield / Dilution	-2.33%	-1.07%	-0.81%	-0.27%	-1.10%	-0.37%
Total Shareholder Return	-2.33%	-1.07%	-0.81%	-0.27%	-1.10%	-0.37%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.